TNFSF13B and fatty liver disease: BAFF neutralization also increased liver steatosis evidenced by increased liver triglyceride levels (Figure 2J). A BAFF ELISA on the plasma of these mice confirmed reduced BAFF levels in the anti-BAFF Ab-treated mice (Figure 2K).